药品生产企业资源重组视角下的新版GMP政策转型升级建议

Suggestions on improving the current GMP for more efficient resources restructuring in pharmaceutical manufacturing enterprises

摘要: 从药品生产企业资源重组角度，进行新版GMP实施存在问题及原因分析，结合我国国情，针对大型、中型和小型3种不同规模药品生产企业，围绕上市许可人制度和委托生产，提出GMP政策转型升级的相关建议。
- 资源重组 /
- GMP /
- 上市许可人制度 /
- 委托生产 /
- 技术转让
Abstract: This paper analyzes the problems in the implementation of current GMP in China, and offers some suggestions on improving it for more efficient resources restructuring in pharmaceutical manufacturing enterprises. Focusing on marketing authorization holder mechanism and the commissioned production approach, the paper proposes specific strategies for upgrading the GMP system to improve the efficiency of resources restructuring in the large-, medium- and small-scale enterprises.
- resources restructuring /
- GMP /
- marketing authorization holder mechanism /
- commissioned production /
- technology transfer

[1]	Yan JZ,Shao R.The influence of market factors on China manufacture enterprises— based on an empirical analysis of provincial panel data model(市场因素对我国制药企业数量的影响——基于跨省际面板数据的实证分析)[C]//The China Pharmaceutical Conference and the 10th China Pharmacist Week.Tianjin:China Pharmaceutical Association,2010.
[2]	Wu L,Sun YY.Research on agglomeration degree in hi-tech industry based on entropy index,concentration ratio and herfindahl index(基于熵指数、行业集中度和HHI指数高技术产业集聚度研究)[C]//The 12th International Conference on Industrial Clustering and Regional Development.Wuhan:China Industrial Clusters Research Coordination Group,2013.
[3]	Du XF.Study on the separation of marketing authorization holder and production license holder(关于药品生产许可与上市许可制度分离的研究)[D].Xi′an:Northwest University,2010.
[4]	Shao R,Chen YF,Xin MH.Research on marketing authorization holder mechanism in China(我国药品上市许可人制度研究)[M]//Tang MH.Food and Drug Safety and Regulatory Research Report(食品药品安全与监管政策研究报).Beijing:Social Sciences Academic Press,2010:152-169.